Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-057012
Filing Date
2020-11-04
Accepted
2020-11-04 19:07:07
Documents
1
Period of Report
2020-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 34768
  Complete submission text file 0001209191-20-057012.txt   36211
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Issuer) CIK: 0001679363 (see all company filings)

EIN.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Business Address
Tipirneni Praveen P. (Reporting) CIK: 0001779978 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38940 | Film No.: 201288129